The transgene-inserted replication-deficit adenovirus vector is effectively used in in vivo gene therapy for peripheral vascular disease and heart disease, including myocardial ischemia, by a single intra-femoral artery or intracoronary injection directly conducted deeply in the lumen of one or both femoral or coronary arteries (or graft vessals) in an amount sufficient for transfecting cells in a desired region.
